CTRI/2022/04/042144已完成未知
A randomized trial to evaluate the role of adjuvant basal cisternostomy in traumatic brain injury patients planned for decompressive craniectomy in a tertiary care center in India. - ABC
King Georges Medical University0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of age 18 years and above presenting with traumatic brain injury having surgically evacuable lesions and brain is bulging after evacuation of hematoma.
排除标准
- •1. Hemodynamic instability (polytrauma cases)
- •2. Pregnant females
- •3. Coagulopathy
- •4. Brain stem dysfunction and signs of irreversible brain damage (b/l fixed dilated pupils)
研究者
相似试验
尚未招募
不适用
A study to know the efficacy of adjuvant IgM in reducing mortality of very low birth weight newborns with sepsisCTRI/2022/09/045566Dr Rinku Saini
进行中（未招募）
3 期
Evaluating the potential benefit of adjuvant chemotherapy for small bowel adenocarcinomaSmall bowel adenocarcinomaCancerISRCTN15070952Greater Glasgow and Clyde Healthboard and University of Glasgow69
尚未招募
不适用
A study to assess effectiveness of hydrogel and honey in treatment of diabetic foot ulcer among diabetic patients residing in rural areas of nelloreCTRI/2020/12/030103arayana College Of Nursing
尚未招募
2 期
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with immune checkpoint blocking antibodies (Nivolumab, Opdivo®; Ipilimumab, Yervoy®) versus observatioNL-OMON50102niversity Hospital Essen30
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlycompletely resected Merkel cell carcinomaMedDRA version: 21.1Level: LLTClassification code 10064025Term: Merkel cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000043-78-DEniversity of Essen190